Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Attendees can expect a comprehensive overview of scientific advances in colorectal cancers, hepatobiliary cancers, immuno-oncology, pancreatic cancers, and much more.

GI Malignancies Debate 2023 - Chicago

GI Malignancies Debate 2023 - Chicago
30 Mar–01 April 2023 | Chicago, IL

GI Malignancies Debate 2023 - Chicago

GI Malignancies Debate 2023 - Chicago
30 Mar–01 April 2023 | Chicago, IL
Attendees can expect a comprehensive overview of scientific advances in colorectal cancers, hepatobiliary cancers, immuno-oncology, pancreatic cancers, and much more.
Ongoing clinical trials on using ctDNA results to guide GI cancer management 2:13
Ongoing clinical trials on using ctDNA results to guide GI cancer management
Suneel Kamath • 4 Apr 2023
ctDNA testing in pancreatic cancer and other upper GI malignancies 1:28
ctDNA testing in pancreatic cancer and other upper GI malignancies
Suneel Kamath • 4 Apr 2023
ctDNA analysis as a part of detecting and monitoring gastrointestinal malignancies 1:12
ctDNA analysis as a part of detecting and monitoring gastrointestinal malignancies
Suneel Kamath • 4 Apr 2023
Perioperative immunotherapy and surgery for treating MSI-high esophagogastric tumors 2:56
Perioperative immunotherapy and surgery for treating MSI-high esophagogastric tumors
Yelena Y. Janjigian • 3 Apr 2023
Debating the peri-operative use of HER2-directed therapies in non-metastatic gastroesophageal cancer 4:19
Debating the peri-operative use of HER2-directed therapies in non-metastatic gastroesophageal cancer
Yelena Y. Janjigian • 3 Apr 2023
Limitations of ctDNA analysis in predicting recurrence of GI malignancies 2:05
Limitations of ctDNA analysis in predicting recurrence of GI malignancies
Suneel Kamath • 4 Apr 2023
Combination therapies to treat hepatocellular carcinoma 6:32
Combination therapies to treat hepatocellular carcinoma
Ghassan Abou-Alfa • 3 Apr 2023
The future of radiotherapy as a treatment for pancreatic cancer 3:03
The future of radiotherapy as a treatment for pancreatic cancer
Joseph Herman • 28 Mar 2023
Alliance trials: Combination of modified FOLFIRINOX and radiotherapy for pancreatic cancer 4:04
Alliance trials: Combination of modified FOLFIRINOX and radiotherapy for pancreatic cancer
Joseph Herman • 28 Mar 2023
How can ctDNA analysis aid in the management of gastrointestinal cancers? 2:40
How can ctDNA analysis aid in the management of gastrointestinal cancers?
Suneel Kamath • 4 Apr 2023
Limitations of using radiotherapy for patients with pancreatic cancer 1:56
Limitations of using radiotherapy for patients with pancreatic cancer
Joseph Herman • 28 Mar 2023
Importance of a multidisciplinary team in developing a treatment plan for pancreatic cancer 2:12
Importance of a multidisciplinary team in developing a treatment plan for pancreatic cancer
Joseph Herman • 28 Mar 2023
FGFR2b: a novel biomarker for patients with gastroesophageal cancer 0:48
FGFR2b: a novel biomarker for patients with gastroesophageal cancer
Nataliya Uboha • 27 Mar 2023
Current and future biomarkers for gastroesophageal cancer 2:45
Current and future biomarkers for gastroesophageal cancer
Nataliya Uboha • 27 Mar 2023
The content of VJOncology is intended for healthcare professionals